We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

    Epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) generally has a favorable prognosis when compared to lung cancer...

    Nino Rafael Müser, Klaus Kirchbacher, Georg-Christian Funk in memo - Magazine of European Medical Oncology
    Article 08 January 2024
  2. Lung cancer-specific symptoms and fear of cancer recurrence among recurrence-free non-small cell lung cancer survivors

    Purpose

    Lung cancer survivors have more psychosocial problems, including depression and anxiety disorder, than other cancer survivors. Lung...

    Genehee Lee, Alice Ahn, ... Juhee Cho in Supportive Care in Cancer
    Article 02 May 2024
  3. Spontaneous histological transformation of lung squamous-cell carcinoma to large cell neuroendocrine carcinoma and small cell lung cancer

    Background

    Histopathological transformation between different types of lung cancer cells has been reported following a variety of anti-tumor...

    **-Dong Li, Cheng-Yan **, ... Chun-Guang Wang in Journal of Cancer Research and Clinical Oncology
    Article 28 June 2023
  4. GABPB1 plays a cancer-promoting role in non-small cell lung cancer

    Background

    GABPB1, the gene that encodes two isoforms of the beta subunit of GABP, has been identified as an oncogene in multiple malignant tumors....

    Tuo Wang, Cong Cao, ... Juanwen Lian in Discover Oncology
    Article Open access 11 March 2024
  5. Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review

    Background

    Currently, immunotherapy is widely used in the treatment of various stages of non-small cell lung cancer. According to clinical experience...

    Yimin Wang, Chuling Li, ... Hongbing Liu in BMC Medicine
    Article Open access 07 November 2022
  6. Predictors of lung cancer subtypes and lymph node status in non-small-cell lung cancer: intravoxel incoherent motion parameters and extracellular volume fraction

    Objective

    To determine the performance of intravoxel incoherent motion (IVIM) parameters and the extracellular volume fraction (ECV) in distinguishing...

    Huizhi Han, Wenxiu Guo, ... Peng Zhao in Insights into Imaging
    Article Open access 06 July 2024
  7. Perioperative immunotherapy for resectable non-small-cell lung cancer

    Lung cancer, of which non-small-cell lung cancer (NSCLC) is the most common type, is the leading cause of cancer-related deaths. Anatomic pulmonary...

    **aodong Yang, Dongliang Bian, ... Peng Zhang in Clinical Cancer Bulletin
    Article Open access 08 January 2024
  8. Comparison of segmentectomy and wedge resection for cT1cN0M0 non-small cell lung cancer

    Objective

    Sublobar resection is considered a standard surgical procedure for early non-small cell lung cancer, although the survival of patients...

    Satoshi Takamori, Makoto Endo, ... Satoshi Shiono in General Thoracic and Cardiovascular Surgery
    Article 08 July 2024
  9. Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer

    Objective

    The purpose of this study was to assess 10-year follow-up outcomes after surgical resection in patients with stage IA invasive non-small...

    **ongfei Li, Fanfan Fan, ... Haiquan Chen in Annals of Surgical Oncology
    Article 18 June 2024
  10. Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer

    Background

    Non-small cell lung cancer (NSCLC) is a major pathological type of lung cancer. However, its pathogenesis remains largely unclear. MRPL35...

    Chengling Zhao, Lei Chen, ... **ao**g Wang in BMC Pulmonary Medicine
    Article Open access 13 December 2023
  11. Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer

    Small-cell lung cancer (SCLC) has traditionally been considered a recalcitrant cancer with a dismal prognosis, with only modest advances in...

    Triparna Sen, Nobuyuki Takahashi, ... Abdul Rafeh Naqash in Nature Reviews Clinical Oncology
    Article 04 July 2024
  12. Metastasis of small cell lung cancer to bilateral extraocular muscles: a case report

    Background

    Orbital metastasis is a possible complication of small cell lung cancer and a pattern of bilateral invasion of the extraocular muscles has...

    João Ponces Ramalhão, Beatriz Costa Vieira, ... Maria Araújo in Journal of Medical Case Reports
    Article Open access 02 May 2024
  13. Bibliometric analysis of the top 100 highly cited articles on sublobectomy for non-small cell lung cancer

    Objectives

    The goal of this research is to pinpoint the top 100 most frequently referenced studies on sublobectomy for non-small cell lung cancer.

    ...
    Chao Guo, Lei Liu, ... Shanqing Li in Journal of Cardiothoracic Surgery
    Article Open access 26 June 2024
  14. Women are Underrepresented in Non-small Cell Lung Cancer Clinical Trials: A Systematic Review

    Purpose

    To perform a systematic review of clinical trials examining non-small cell lung cancer (NSCLC) to better understand the equity afforded to...

    Savan K. Shah, Vaishnavi Krishnan, ... Gillian C. Alex in Annals of Surgical Oncology
    Article 10 July 2024
  15. Brain metastases from small cell lung cancer and non-small cell lung cancer: comparison of spatial distribution and identification of metastatic risk regions

    Purpose

    This study aims to investigate the spatial distribution difference of brain metastases (BM) between small-cell lung cancer (SCLC) and...

    Wei Shi, Yong Wang, ... **n Gao in Journal of Neuro-Oncology
    Article 15 December 2022
  16. CircBRIP1: a plasma diagnostic marker for non-small-cell lung cancer

    Background

    Circular RNA (circRNA), which has been demonstrated in studies to be abundantly prevalent in tumor cells and bodily fluids and to play a...

    **nfeng Fan, Qi Zhang, ... Shaoqing Ju in Journal of Cancer Research and Clinical Oncology
    Article Open access 08 February 2024
  17. Novel Therapeutic Options for Small Cell Lung Cancer

    Purpose of Review

    The aim of this review is to focus on the recent advances in the molecular knowledge of small cell lung cancer (SCLC) and potential...

    Stefania Canova, Benedetta Trevisan, ... Diego Luigi Cortinovis in Current Oncology Reports
    Article Open access 23 October 2023
  18. Genetically-engineered mouse models of small cell lung cancer: the next generation

    Small cell lung cancer (SCLC) remains the most fatal form of lung cancer, with patients in dire need of new and effective therapeutic approaches....

    Matthew G. Oser, David MacPherson, ... Kwon-Sik Park in Oncogene
    Article 08 January 2024
  19. Significance of preoperative evaluation of modified advanced lung cancer inflammation index for patients with resectable non-small cell lung cancer

    Objectives

    Body composition and systemic inflammation/nutrition have been identified as important clinical factors in cancer patients. The modified...

    Seijiro Sato, Ryo Sezaki, Hirohiko Shinohara in General Thoracic and Cardiovascular Surgery
    Article 22 January 2024
  20. Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer

    Lung Cancer, the second most common cancer worldwide, remains the leading cause of cancer-related deaths, contemporarily. More than 85% of identified...

    Jennifer Sally Samson, Venkatachalam Deepa Parvathi in Medical Oncology
    Article 03 November 2023
Did you find what you were looking for? Share feedback.